We further evaluated the clinical impact of copy number alterations of ITGA1/ITGA2 on PCa progression and therefore conducted the Kaplan‐Meier survival analysis to examine the association of ITGA1/ITGA2 copy number loss/del and patient prognosis in multiple independent PCa cohorts. The gene discussed is ITGA2; the disease is posterior cortical atrophy.